Kim Lorence H. sells $11.4M of RVMDKim Lorence H. 内部减持 RVMD $11.4M
What happened
Kim Lorence H. (director) sold 56,000 shares of Revolution Medicines, Inc. (RVMD) on 2026-08-31, at an average price of $203.24, for approximately $11.4M. The transaction was disclosed on 2026-09-02 in the SEC Form 4.
Why it matters
The transaction equals about 0.026% of the company's reported market capitalization. This is a completed and reported insider sale, not a Form 144 planned-sale notice; without post-trade ownership and trading-plan context, one sale alone does not establish a bearish insider view.
What to watch next
Watch the next Form 4 for repeated same-direction transactions, post-transaction ownership, and whether the filing identifies a Rule 10b5-1 trading plan.
发生了什么
Kim Lorence H.（director）于 2026-08-31 卖出 Revolution Medicines, Inc.（RVMD）56,000 股，平均价格 $203.24，合计约 $11.4M。该交易于 2026-09-02 通过 SEC 原始 Form 4 披露。
为什么重要
本次交易金额约占公司市值的 0.026%。这是已经成交并申报的内部人卖出，不是 Form 144 拟出售计划；缺少交易后持股和交易安排时，单笔卖出不能单独证明内部人看空。
后续关注
下一份 Form 4 是否出现连续同向交易、交易后持股数量，以及申报是否说明交易依据 10b5-1 计划执行。
This ownership brief was prepared only from the linked SEC Form 4 and structured transaction fields. It distinguishes a completed Form 4 trade from a Form 144 planned-sale notice and does not infer a view from unrelated holdings, ratings, or market data. It is for informational purposes only and does not constitute investment advice.这篇持仓快讯仅依据页面链接的 SEC Form 4 及其结构化交易字段整理；明确区分已经成交的 Form 4 交易与 Form 144 拟出售计划，不引用无关持仓、评级或行情来推断内部人观点。内容仅供参考，不构成投资建议。